<code id='FDB03870B0'></code><style id='FDB03870B0'></style>
    • <acronym id='FDB03870B0'></acronym>
      <center id='FDB03870B0'><center id='FDB03870B0'><tfoot id='FDB03870B0'></tfoot></center><abbr id='FDB03870B0'><dir id='FDB03870B0'><tfoot id='FDB03870B0'></tfoot><noframes id='FDB03870B0'>

    • <optgroup id='FDB03870B0'><strike id='FDB03870B0'><sup id='FDB03870B0'></sup></strike><code id='FDB03870B0'></code></optgroup>
        1. <b id='FDB03870B0'><label id='FDB03870B0'><select id='FDB03870B0'><dt id='FDB03870B0'><span id='FDB03870B0'></span></dt></select></label></b><u id='FDB03870B0'></u>
          <i id='FDB03870B0'><strike id='FDB03870B0'><tt id='FDB03870B0'><pre id='FDB03870B0'></pre></tt></strike></i>

          Home / entertainment / leisure time

          leisure time


          leisure time

          author:fashion    Page View:1
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In